Institution Information
| Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
|---|---|---|---|---|
| ROSALIND ADVISORS INC | 02-14-2024 | 12-31-2023 | 30 | 121,420,416,000 |
Institutional Holdings
| Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
|---|---|---|---|---|---|---|---|---|---|
| LYRA THERAPEUTICS INC | COM | 1 | $9,896,893,000 | 1,888,720 | 8.15 | 1,888,720 | +Inf | 12-31-2023 | |
| MYOMO INC-NEW | COM NEW | 2 | $9,618,749,000 | 1,919,910 | 7.92 | 1,919,910 | +Inf | 12-31-2023 | |
| ASTRIA THERAPEUTICS INC | COM | 3 | $8,668,477,000 | 1,128,708 | 7.14 | 1,128,708 | +Inf | 12-31-2023 | |
| XERIS BIOPHARMA HLDGS INC | COM | 4 | $8,327,660,000 | 3,543,685 | 6.86 | 3,543,685 | +Inf | 12-31-2023 |
